IMARA Inc. (43)

Browse by Contract Category

Contracts

Enliven Therapeutics, Inc. 2019 Equity Incentive Plan, as amended, including forms of agreements thereunder (Filed With SEC on November 10, 2022)
Asset Purchase Agreement, dated September 6, 2022, between the Company and Cardurion Pharmaceuticals, Inc (Filed With SEC on September 7, 2022)
Second Amendment and Termination of Office Lease Agreement, effective July 21, 2022, between the Registrant and Columbia REIT 116 Huntington, LLC (Filed With SEC on July 29, 2022)
Amendment Number 3 to Exclusive License Agreement, dated as of April 29, 2022, by and between H. Lundbeck A/S and the Registrant (Filed With SEC on May 6, 2022)
First Amendment to the Letter Agreement, dated as of November 5, 2021, by and between the Registrant and Kenneth M. Attie, M.D (Filed With SEC on March 15, 2022)
Form of Indemnification Agreement with directors and executive officers (Filed With SEC on February 14, 2020)
Amendment to Amended and Restated Retention Agreement, dated as of May 18, 2022, by and between the Company and Michael P. Gray (Filed With SEC on September 7, 2022)
Amendment to Retention Agreement, dated as of May 5, 2022, by and between the Company and Rahul D. Ballal, Ph.D (Filed With SEC on September 7, 2022)
Amended and Restated Retention Agreement, dated as of May 18, 2022, by and between the Registrant and Michael P. Gray (Filed With SEC on August 3, 2022)
Separation Agreement and General Release, dated as of April 21, 2022, by and between the Registrant and Kenneth M. Attie, M.D (Filed With SEC on May 6, 2022)
Retention Agreement, dated as of May 5, 2022, by and between the Registrant and Rahul D. Ballal, Ph.D (Filed With SEC on May 6, 2022)
Retention Agreement, dated as of May 5, 2022, by and between the Registrant and Michael P. Gray (Filed With SEC on May 6, 2022)
Letter Agreement, dated as of December 4, 2020, by and between the Registrant and Kenneth M. Attie, M.D (Filed With SEC on March 15, 2022)
First Amendment to Non-Exclusive License Agreement, dated as of December 8, 2021, by and between the University of Pittsburgh Of the Commonwealth System of Higher Education and... (Filed With SEC on March 15, 2022)
Non-Exclusive License Agreement, dated as of May 27, 2021, by and between the University of Pittsburgh Of the Commonwealth System of Higher Education and the Registrant (Filed With SEC on March 15, 2022)
Exclusive License Agreement, dated as of April 23, 2012, by and between the UAB Research Foundation and the Registrant (as successor-in-interest to Complexa, Inc.) (Filed With SEC on March 15, 2022)
Form of Restricted Stock Unit Agreement under the 2020 Equity Incentive Plan (Filed With SEC on March 15, 2022)
Asset Purchase Agreement, dated October 19, 2020, by and between Complexa (assignment for the benefit of creditors), LLC and the Registrant (Filed With SEC on March 15, 2022)
First Amendment to the Amended and Restated Letter Agreement, dated as of November 5, 2021, by and between the Registrant and Michael P. Gray (Filed With SEC on November 9, 2021)
First Amendment to the Amended and Restated Letter Agreement, dated as of November 5, 2021, by and between the Registrant and Rahul D. Ballal, Ph.D (Filed With SEC on November 9, 2021)
Underwriting Agreement, dated July 13, 2021, by and among IMARA Inc., with Morgan Stanley & Co. LLC and SVB Leerink LLC, as representatives of the several underwriters identified... (Filed With SEC on July 14, 2021)
First Amendment to Office Lease Agreement, dated June 8, 2021, by and between the Company and Columbia REIT 116 Huntington, LLC (Filed With SEC on June 11, 2021)
Description of Securities of the Registrant (Filed With SEC on March 5, 2021)
Separation and Release of Claims Agreement, dated as of May 1, 2020, by and between the Registrant and Willem H. Scheele, M.D (Filed With SEC on August 14, 2020)
2016 Stock Incentive Plan, as amended (Filed With SEC on March 3, 2020)
2020 Equity Incentive Plan (Filed With SEC on March 3, 2020)
2020 Employee Stock Purchase Plan (Filed With SEC on March 3, 2020)
Form of Underwriting Agreement (Filed With SEC on March 3, 2020)
Amended and Restated Letter Agreement, dated as of September 23, 2019, by and between the Registrant and Michael P. Gray (Filed With SEC on February 14, 2020)
Amended and Restated Letter Agreement, dated as of September 23, 2019, by and between the Registrant and Willem H. Scheele, M.D (Filed With SEC on February 14, 2020)
Amended and Restated Letter Agreement, dated as of September 23, 2019, by and between the Registrant and Rahul D. Ballal, Ph.D (Filed With SEC on February 14, 2020)
Exclusive License Agreement, dated as of April 11, 2016, by and between H. Lundbeck A/S and the Registrant, as amended (Filed With SEC on February 14, 2020)
Form of Indemnification Agreement to be entered into between the Registrant and each of its directors and executive officers (to be effective immediately prior to the... (Filed With SEC on February 14, 2020)
Form of Stock Option Agreement under the 2020 Equity Incentive Plan (Filed With SEC on February 14, 2020)
2020 Equity Incentive Plan (Filed With SEC on February 14, 2020)
Form of Nonstatutory Stock Option Agreement under the 2016 Stock Incentive Plan (Filed With SEC on February 14, 2020)
Form of Incentive Stock Option Agreement under the 2016 Stock Incentive Plan (Filed With SEC on February 14, 2020)
2016 Stock Incentive Plan, as amended (Filed With SEC on February 14, 2020)
Amended and Restated Investors Rights Agreement, dated as of March 15, 2019, by and among the Registrant and the other parties thereto (Filed With SEC on February 14, 2020)
Specimen stock certificate evidencing the shares of common stock (Filed With SEC on February 14, 2020)
Office Lease Agreement, dated as of May 20, 2019, by and between Columbia REIT 116 Huntington, LLC and the Registrant (Filed With SEC on February 14, 2020)
Form of Restricted Stock Unit Agreement under the 2020 Equity Incentive Plan (Filed With SEC on February 14, 2020)
2020 Employee Stock Purchase Plan (Filed With SEC on February 14, 2020)